Intermolecular (IMI) Reports In-Line Q2 EPS; Issues Light Q3 Outlook

Intermolecular (NASDAQ: IMI) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $12.2 million.

GUIDANCE:

Intermolecular sees Q3 2016 EPS of ($0.12)-($0.10), versus the consensus of ($0.03). Intermolecular sees Q3 2016 revenue of $9.5-10.0 million, versus the consensus of $14.2 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• PBF Energy (PBF) PT Raised to $57 at Mizuho
• Airbnb Inc. (ABNB) PT Raised to $175 at Jefferies